Genentech discontinues cell therapy collaboration with Adaptimmune
FierceBiotech - 12-Apr-2024The company remains focused on its independent cancer drug development
Join the club for FREE to access the whole archive and other member benefits.
Company creating and delivering innovative medicines.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Genentech became a member of the Roche Group in March of 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech's South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development operates as an independent center within Roche.
Visit website: https://www.gene.com/
Details last updated 30-Jan-2020
The company remains focused on its independent cancer drug development
$ 80 million will be directed towards Alzheimer’s research and drug discovery